In this issue of Blood , Lubenow and colleagues provide the first strong evidence that there is much more besides heparin in triggering the adverse drug reaction, HIT.[1][1] To date, research has focused on identifying whether differences in heparin composition influence the risk of immunization
No takes yet. Share an insight, caveat, or question.
Theodore E. Warkentin (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: